<DOC>
	<DOCNO>NCT02521103</DOCNO>
	<brief_summary>This study prospective , open-label , post-market , non-randomized , multi-center clinical evaluation Triathlon TS Total Knee System Triathlon Tritanium Cone Augments revision total knee arthroplasty ( TKA ) consecutive series patient meet eligibility criterion . The revision rate Triathlon Tritanium Cone Augments expect less 2.8 % aseptic loosening either Femoral Tibial Cone Augments 2 year postoperative .</brief_summary>
	<brief_title>Triathlon Tritanium Cone Augments Outcomes Study</brief_title>
	<detailed_description />
	<criteria>Patient sign Institutional Review Board ( IRB ) /Ethics Committee ( EC ) approve , study specific Informed Patient Consent Form . Patient male nonpregnant female , skeletally mature age 18 year old time study device implantation . Patient candidate revision femoral tibial component total knee replacement . Patient willing able comply postoperative schedule clinical radiographic evaluation rehabilitation . Patient Body Mass Index ( BMI ) â‰¥ 40 . Patient active suspect latent infection affect knee joint time study device implantation . Patient neuromuscular neurosensory deficiency , limit ability evaluate safety efficacy device . Patient diagnose systemic disease ( e.g . Lupus Erythematosus ) metabolic disorder ( e.g . Paget 's disease ) lead progressive bone deterioration . Patient immunologically suppress receive steroid excess normal physiological requirement ( e.g . &gt; 30 day ) . Patient fail unicondylar knee prosthesis . Patient known sensitivity device material . Patient prisoner .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>